SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 7, 2002
CRYOLIFE, INC.
(Exact name of registrant as specified in its charter)
Florida
(State or other jurisdiction of incorporation)
1-13165 59-2417093
(Commission File Number) (IRS Employer Identification No.)
1655 Roberts Boulevard N.W., Kennesaw, Georgia 30144
(Address of principal executive offices, including zip code)
(770) 419-3355
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Item 4. Changes in Registrant's Certifying Accountant.
On May 7, 2002, CryoLife, Inc. ("CryoLife") engaged Deloitte & Touche, LLP
("Deloitte") as its independent auditors. The decision to engage Deloitte was
recommended by the Audit Committee and was approved by the Board of Directors of
CryoLife. The engagement will be effective immediately. Deloitte replaces the
firm of Arthur Andersen LLP as independent auditors of CryoLife. On April 9,
2002, CryoLife dismissed Arthur Andersen as its independent auditors.
Neither CryoLife nor anyone engaged on its behalf has consulted with Deloitte
during CryoLife's two most recently completed fiscal years or during its current
fiscal year with regard to either: (i) the application of accounting principles
to a specified transaction, either completed or proposed, or the type of audit
opinion that might be rendered on CryoLife's financial statements; or (ii) any
matter that was either the subject of a disagreement (as defined in Item
304(a)(1)(iv) of Regulation S-K and the related instructions) or a reportable
event (as described in Item 304(a)(1)(v) of Regulation S-K).
CryoLife hereby incorporates by reference herein the information set forth in
its press release dated May 7, 2002, a copy of which is attached hereto as
Exhibit 99.1
Item 7. Financial Statements and Exhibits.
(a) Financial Statements.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Exhibit Number Description
99.1 Press Release dated May 7, 2002
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife
has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
CRYOLIFE, INC.
Date: May 10, 2002 By: /s/ D. Ashley Lee
--------------------------------
Name: D. Ashley Lee
Title: Vice President, Chief
Financial Officer
3
EXHIBIT INDEX
Exhibit Number Description Page
99.1 Press Release dated May 7, 2002
1461480